Therapeutic targets & mechanisms for treatment

Dementia and Alzheimer's disease (AD) as of now exhibits one of the greatest medicinal services issues in the created nations. There is no successful treatment equipped for backing off infection movement. As of late the fundamental concentrate of research on novel pharmacotherapies depended on the amyloidogenic speculation of AD, which places that the beta amyloid (Aβ) peptide is primarily in charge of subjective hindrance and neuronal demise. The objective of such medicines is (a) to diminish Aβ creation through the restraint of β and γ secretase chemicals and (b) to advance disintegration of existing cerebral Aβ plaques. Be that as it may, this approach has turned out to be just unobtrusively viable. Late investigations propose an option methodology fixated on the restraint of the downstream Aβ flagging, especially at the neural connection. Aβ oligomers may cause deviant N-methyl-D-aspartate receptor (NMDAR) initiation postsynaptically by shaping buildings with the phone surface prion protein (PrPC). PrPC is enhanced at the neuronal postsynaptic thickness, where it collaborates with Fyn tyrosine kinase. Fyn enactment happens when Aβ is bound to PrPC-Fyn complex. Fyn causes tyrosine phosphorylation of the NR2B subunit of metabotropic glutamate receptor 5 (mGluR5). Fyn kinase blockers masitinib and saracatinib have ended up being effective in treating AD side effects in trial mouse models of the illness.

    Related Conference of Therapeutic targets & mechanisms for treatment

    December 01-02, 2025

    38th European Neurology Congress 2025

    Vancouver, Canada
    December 04-05, 2025

    17th Global Neurologists Meeting on Neurology and Neurosurgery

    Amsterdam, Netherlands
    December 15-16, 2025

    20th Annual Congress on Neuroscience

    Paris, France
    January 29-30, 2026

    29th International Conference on Viral Infections & Virology

    Aix-en-Provence, France
    February 02-03, 2026

    7th Global Summit on Brain Disorders and Therapeutics

    Paris, France
    February 12-13, 2026

    8th World Conference on Neuroscience

    Singapore City, Singapore
    February 16-17, 2026

    18th International Conference on Neurology and Neuromuscular Disorders

    Paris, France
    March 09-10, 2026

    30th International Conference on Neurology & Neurophysiology

    London, UK
    March 09-10, 2026

    7th International Conference on Neurologists

    Singapore City, Singapore
    March 18-19, 2026

    9th International Conference on Neurology and Psychology

    London, UK
    March 23-24, 2026

    17th International Conference on Stroke, Neurology and Cerebrovascular Diseases

    Paris, France
    March 23-24, 2026

    5th International Conference on Alzheimer and Dementia

    Tokyo, Japan
    March 26-27, 2026

    6th Global congress on Neuroscience Psychiatry and Mental Disorder

    Paris, France
    April 16-17, 2026

    9th World Congress on Epilepsy and Brain Disorders

    Tokyo, Japan
    April 16-17, 2026

    32st International conference on Neurosurgery and Brain Disorders

    Tokyo, Japan
    April 16-17, 2026

    21st Annual Conference on Dementia and Alzheimers Disease

    Tokyo, Japan
    April 20-21, 2026

    56th International Conference on Psychology, Mindfulness & Stress Adaptation

    Acerra, Italy
    April 23-24, 2026

    8th World Depression Congress

    Paris, France
    May 14-15, 2026

    9th World Conference on Neuroscience

    Rome, Italy
    May 18-19, 2026

    38th International conference on Mental Health and Psychiatry

    Aix-en-Provence, France
    May 26-27, 2026

    7th International Summit on Mental Disorders and Illness

    Paris, France
    June 22-23, 2026

    7th World Congress on Sleep Disorders and Therapeutics

    Amsterdam, Netherlands
    June 29-30, 2026

    31st International Conference on Neurology: Neurochemistry, Neuropharmacology and Neurosciences

    Aix-en-Provence, France
    June 29-30, 2026

    37th Conference on Clinical Neuroscience and Neurogenetics

    Aix-en-Provence, France
    July 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    September 17-18, 2026

    31st Global Experts Meeting on Neuroscience and Neuropharmacology

    Paris, France

    Therapeutic targets & mechanisms for treatment Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in